Nekado T - Search Results

1

Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study.

Yasumatsu R, Shimizu Y, Hanai N, Kariya S, Yokota T, Fujii T, Tsukahara K, Ando M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Nekado T, Yamada T, Homma A. Yasumatsu R, et al. Among authors: nekado t. Int J Clin Oncol. 2022 Jan;27(1):95-104. doi: 10.1007/s10147-021-02047-y. Epub 2021 Nov 13. Int J Clin Oncol. 2022. PMID: 34773525 Free PMC article.

2

Synthesis of ganglioside GM3 and GM4 analogs having mimics of ceramide moieties and their binding activities with influenza virus A.

Nagao Y, Nekado T, Ikeda K, Achiwa K. Nagao Y, et al. Among authors: nekado t. Chem Pharm Bull (Tokyo). 1995 Sep;43(9):1536-42. doi: 10.1248/cpb.43.1536. Chem Pharm Bull (Tokyo). 1995. PMID: 7586078

3

Synthesis of Tn and sialyl Tn antigen-lipid A analog conjugates for synthetic vaccines.

Miyajima K, Nekado T, Ikeda K, Achiwa K. Miyajima K, et al. Among authors: nekado t. Chem Pharm Bull (Tokyo). 1997 Sep;45(9):1544-6. doi: 10.1248/cpb.45.1544. Chem Pharm Bull (Tokyo). 1997. PMID: 9332007

4

Synthesis of Tn, sialyl Tn and HIV-1-derived peptide antigen conjugates having a lipid A analog as an immunoadjuvant for synthetic vaccines.

Miyajima K, Nekado T, Ikeda K, Achiwa K. Miyajima K, et al. Among authors: nekado t. Chem Pharm Bull (Tokyo). 1998 Nov;46(11):1676-82. doi: 10.1248/cpb.46.1676. Chem Pharm Bull (Tokyo). 1998. PMID: 9845951

5

Design and synthesis of long-acting inhibitors of dipeptidyl peptidase IV.

Kondo T, Sugimoto I, Nekado T, Ochi K, Ohtani T, Tajima Y, Yamamoto S, Kawabata K, Nakai H, Toda M. Kondo T, et al. Among authors: nekado t. Bioorg Med Chem. 2007 Apr 1;15(7):2715-35. doi: 10.1016/j.bmc.2007.01.033. Epub 2007 Jan 20. Bioorg Med Chem. 2007. PMID: 17292611

6

Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration.

Kondo T, Nekado T, Sugimoto I, Ochi K, Takai S, Kinoshita A, Tajima Y, Yamamoto S, Kawabata K, Nakai H, Toda M. Kondo T, et al. Among authors: nekado t. Bioorg Med Chem. 2007 Apr 1;15(7):2631-50. doi: 10.1016/j.bmc.2007.01.041. Epub 2007 Jan 26. Bioorg Med Chem. 2007. PMID: 17293118

7

Discovery of long-acting N-(cyanomethyl)-N-alkyl-L-prolinamide inhibitors of dipeptidyl peptidase IV.

Kondo T, Nekado T, Sugimoto I, Ochi K, Takai S, Kinoshita A, Hatayama A, Yamamoto S, Kawabata K, Nakai H, Toda M. Kondo T, et al. Among authors: nekado t. Bioorg Med Chem. 2008 Jan 1;16(1):190-208. doi: 10.1016/j.bmc.2007.10.005. Epub 2007 Oct 5. Bioorg Med Chem. 2008. PMID: 17962025

8

Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group.

Kondo T, Nekado T, Sugimoto I, Ochi K, Takai S, Kinoshita A, Hatayama A, Yamamoto S, Kishikawa K, Nakai H, Toda M. Kondo T, et al. Among authors: nekado t. Bioorg Med Chem. 2008 Feb 15;16(4):1613-31. doi: 10.1016/j.bmc.2007.11.031. Epub 2007 Nov 17. Bioorg Med Chem. 2008. PMID: 18039579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters